CCI vs MRSN · P/E 40, rev $2.02B vs rev $40.5M
Crown Castle (CCI) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2026-06-30 was $2.02B. Net income was $245.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the CCI and MRSN stock pages for the full models.
Not investment advice.